Amlexanox Reduced Brain Cell Injury in Mouse Study

Researchers found the drug, a PDE4B inhibitor, helped preserve hippocampal neurons following induced brain ischemia.

Updated on Sept. 26, 2026 in Stroke

A close-up view of a laboratory pipette and glassware on a stainless steel surface, representing neuroprotective medical research.
Researchers identified that the drug amlexanox helped protect brain cells from damage following induced ischemia in a new mouse study. AI Illustration. Upload story photo >

In a new mouse study, researchers observed that administering the drug amlexanox helped protect brain tissue after induced global cerebral ischemia. This preclinical finding suggests a potential avenue for mitigating neuronal damage in the future.

Why it matters

Understanding how to limit neuronal degeneration after an ischemic event is a major focus for developing neuroprotective therapies. While the research is preliminary, it identifies a potential mechanism for preserving brain cell integrity that scientists may explore further.

In a preclinical study, daily administration of 10 mg/kg of amlexanox helped preserve hippocampal neuronal integrity in a mouse model of global cerebral ischemia. The research is preliminary, as findings in animal models do not always translate to clinical outcomes in humans.

The details

Amlexanox functions as an inhibitor of the enzyme phosphodiesterase 4B (PDE4B). By reducing the expression of PDE4B, the treatment appeared to influence cellular processes associated with autophagy and lysosomes, which help clear damaged cellular components. This modulation also affected the expression of proteins linked to apoptosis, ultimately supporting neuronal survival after ischemia.

Timeline

  1. September 26, 2026: The research findings were officially published.

Health Landscape

This study aligns with broader efforts in neuroprotective research targeting ischemia-induced neuronal injury. It adds to the experimental evidence base exploring how modulating enzymatic pathways might provide a defense against tissue damage following reduced blood flow to the brain.

This is a laboratory study in mice and does not change clinical treatment protocols or the standard of care for stroke patients today. Patients should always consult with a neurologist regarding current evidence-based strategies for brain health and stroke prevention.

The takeaway

While this study offers an interesting look at potential neuroprotective mechanisms, it remains in the early, experimental stages. Readers focused on brain health should continue to prioritize established preventive measures, such as blood pressure management, and discuss individual risks with a doctor.

Further reading

For more on the current science of preventing and managing brain cell damage, explore our Stroke archive.

Source note: This article includes information reported by Nature.